Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study
Since December 2019, the 2019 coronavirus disease (COVID-19) has expanded to cause a worldwide outbreak that more than 600,000 people infected and tens of thousands died. To date, the clinical characteristics of COVID-19 patients in the non-Wuhan areas of Hubei Province in China have not been descri...
Saved in:
Published in | BMC infectious diseases Vol. 20; no. 1; pp. 311 - 8 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
29.04.2020
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Since December 2019, the 2019 coronavirus disease (COVID-19) has expanded to cause a worldwide outbreak that more than 600,000 people infected and tens of thousands died. To date, the clinical characteristics of COVID-19 patients in the non-Wuhan areas of Hubei Province in China have not been described.
We retrospectively analyzed the clinical characteristics and treatment progress of 91 patients diagnosed with COVID-19 in Jingzhou Central Hospital.
Of the 91 patients diagnosed with COVID-19, 30 cases (33.0%) were severe and two patients (2.2%) died. The severe disease group tended to be older (50.5 vs. 42.0 years; p = 0.049) and have more chronic disease (40% vs. 14.8%; p = 0.009) relative to mild disease group. Only 73.6% of the patients were quantitative polymerase chain reaction (qPCR)-positive on their first tests, while typical chest computed tomography images were obtained for each patient. The most common complaints were cough (n = 75; 82.4%), fever (n = 59; 64.8%), fatigue (n = 35; 38.5%), and diarrhea (n = 14; 15.4%). Non-respiratory injury was identified by elevated levels of aspartate aminotransferase (n = 18; 19.8%), creatinine (n = 5; 5.5%), and creatine kinase (n = 14; 15.4%) in laboratory tests. Twenty-eight cases (30.8%) suffered non-respiratory injury, including 50% of the critically ill patients and 21.3% of the mild patients.
Overall, the mortality rate of patients in Jingzhou was lower than that of Wuhan. Importantly, we found liver, kidney, digestive tract, and heart injuries in COVID-19 cases besides respiratory problems. Combining chest computed tomography images with the qPCR analysis of throat swab samples can improve the accuracy of COVID-19 diagnosis. |
---|---|
AbstractList | Abstract Background Since December 2019, the 2019 coronavirus disease (COVID-19) has expanded to cause a worldwide outbreak that more than 600,000 people infected and tens of thousands died. To date, the clinical characteristics of COVID-19 patients in the non-Wuhan areas of Hubei Province in China have not been described. Methods We retrospectively analyzed the clinical characteristics and treatment progress of 91 patients diagnosed with COVID-19 in Jingzhou Central Hospital. Results Of the 91 patients diagnosed with COVID-19, 30 cases (33.0%) were severe and two patients (2.2%) died. The severe disease group tended to be older (50.5 vs. 42.0 years; p = 0.049) and have more chronic disease (40% vs. 14.8%; p = 0.009) relative to mild disease group. Only 73.6% of the patients were quantitative polymerase chain reaction (qPCR)-positive on their first tests, while typical chest computed tomography images were obtained for each patient. The most common complaints were cough (n = 75; 82.4%), fever (n = 59; 64.8%), fatigue (n = 35; 38.5%), and diarrhea (n = 14; 15.4%). Non-respiratory injury was identified by elevated levels of aspartate aminotransferase (n = 18; 19.8%), creatinine (n = 5; 5.5%), and creatine kinase (n = 14; 15.4%) in laboratory tests. Twenty-eight cases (30.8%) suffered non-respiratory injury, including 50% of the critically ill patients and 21.3% of the mild patients. Conclusions Overall, the mortality rate of patients in Jingzhou was lower than that of Wuhan. Importantly, we found liver, kidney, digestive tract, and heart injuries in COVID-19 cases besides respiratory problems. Combining chest computed tomography images with the qPCR analysis of throat swab samples can improve the accuracy of COVID-19 diagnosis. Since December 2019, the 2019 coronavirus disease (COVID-19) has expanded to cause a worldwide outbreak that more than 600,000 people infected and tens of thousands died. To date, the clinical characteristics of COVID-19 patients in the non-Wuhan areas of Hubei Province in China have not been described.BACKGROUNDSince December 2019, the 2019 coronavirus disease (COVID-19) has expanded to cause a worldwide outbreak that more than 600,000 people infected and tens of thousands died. To date, the clinical characteristics of COVID-19 patients in the non-Wuhan areas of Hubei Province in China have not been described.We retrospectively analyzed the clinical characteristics and treatment progress of 91 patients diagnosed with COVID-19 in Jingzhou Central Hospital.METHODSWe retrospectively analyzed the clinical characteristics and treatment progress of 91 patients diagnosed with COVID-19 in Jingzhou Central Hospital.Of the 91 patients diagnosed with COVID-19, 30 cases (33.0%) were severe and two patients (2.2%) died. The severe disease group tended to be older (50.5 vs. 42.0 years; p = 0.049) and have more chronic disease (40% vs. 14.8%; p = 0.009) relative to mild disease group. Only 73.6% of the patients were quantitative polymerase chain reaction (qPCR)-positive on their first tests, while typical chest computed tomography images were obtained for each patient. The most common complaints were cough (n = 75; 82.4%), fever (n = 59; 64.8%), fatigue (n = 35; 38.5%), and diarrhea (n = 14; 15.4%). Non-respiratory injury was identified by elevated levels of aspartate aminotransferase (n = 18; 19.8%), creatinine (n = 5; 5.5%), and creatine kinase (n = 14; 15.4%) in laboratory tests. Twenty-eight cases (30.8%) suffered non-respiratory injury, including 50% of the critically ill patients and 21.3% of the mild patients.RESULTSOf the 91 patients diagnosed with COVID-19, 30 cases (33.0%) were severe and two patients (2.2%) died. The severe disease group tended to be older (50.5 vs. 42.0 years; p = 0.049) and have more chronic disease (40% vs. 14.8%; p = 0.009) relative to mild disease group. Only 73.6% of the patients were quantitative polymerase chain reaction (qPCR)-positive on their first tests, while typical chest computed tomography images were obtained for each patient. The most common complaints were cough (n = 75; 82.4%), fever (n = 59; 64.8%), fatigue (n = 35; 38.5%), and diarrhea (n = 14; 15.4%). Non-respiratory injury was identified by elevated levels of aspartate aminotransferase (n = 18; 19.8%), creatinine (n = 5; 5.5%), and creatine kinase (n = 14; 15.4%) in laboratory tests. Twenty-eight cases (30.8%) suffered non-respiratory injury, including 50% of the critically ill patients and 21.3% of the mild patients.Overall, the mortality rate of patients in Jingzhou was lower than that of Wuhan. Importantly, we found liver, kidney, digestive tract, and heart injuries in COVID-19 cases besides respiratory problems. Combining chest computed tomography images with the qPCR analysis of throat swab samples can improve the accuracy of COVID-19 diagnosis.CONCLUSIONSOverall, the mortality rate of patients in Jingzhou was lower than that of Wuhan. Importantly, we found liver, kidney, digestive tract, and heart injuries in COVID-19 cases besides respiratory problems. Combining chest computed tomography images with the qPCR analysis of throat swab samples can improve the accuracy of COVID-19 diagnosis. Since December 2019, the 2019 coronavirus disease (COVID-19) has expanded to cause a worldwide outbreak that more than 600,000 people infected and tens of thousands died. To date, the clinical characteristics of COVID-19 patients in the non-Wuhan areas of Hubei Province in China have not been described. We retrospectively analyzed the clinical characteristics and treatment progress of 91 patients diagnosed with COVID-19 in Jingzhou Central Hospital. Of the 91 patients diagnosed with COVID-19, 30 cases (33.0%) were severe and two patients (2.2%) died. The severe disease group tended to be older (50.5 vs. 42.0 years; p = 0.049) and have more chronic disease (40% vs. 14.8%; p = 0.009) relative to mild disease group. Only 73.6% of the patients were quantitative polymerase chain reaction (qPCR)-positive on their first tests, while typical chest computed tomography images were obtained for each patient. The most common complaints were cough (n = 75; 82.4%), fever (n = 59; 64.8%), fatigue (n = 35; 38.5%), and diarrhea (n = 14; 15.4%). Non-respiratory injury was identified by elevated levels of aspartate aminotransferase (n = 18; 19.8%), creatinine (n = 5; 5.5%), and creatine kinase (n = 14; 15.4%) in laboratory tests. Twenty-eight cases (30.8%) suffered non-respiratory injury, including 50% of the critically ill patients and 21.3% of the mild patients. Overall, the mortality rate of patients in Jingzhou was lower than that of Wuhan. Importantly, we found liver, kidney, digestive tract, and heart injuries in COVID-19 cases besides respiratory problems. Combining chest computed tomography images with the qPCR analysis of throat swab samples can improve the accuracy of COVID-19 diagnosis. Background Since December 2019, the 2019 coronavirus disease (COVID-19) has expanded to cause a worldwide outbreak that more than 600,000 people infected and tens of thousands died. To date, the clinical characteristics of COVID-19 patients in the non-Wuhan areas of Hubei Province in China have not been described. Methods We retrospectively analyzed the clinical characteristics and treatment progress of 91 patients diagnosed with COVID-19 in Jingzhou Central Hospital. Results Of the 91 patients diagnosed with COVID-19, 30 cases (33.0%) were severe and two patients (2.2%) died. The severe disease group tended to be older (50.5 vs. 42.0 years; p = 0.049) and have more chronic disease (40% vs. 14.8%; p = 0.009) relative to mild disease group. Only 73.6% of the patients were quantitative polymerase chain reaction (qPCR)-positive on their first tests, while typical chest computed tomography images were obtained for each patient. The most common complaints were cough (n = 75; 82.4%), fever (n = 59; 64.8%), fatigue (n = 35; 38.5%), and diarrhea (n = 14; 15.4%). Non-respiratory injury was identified by elevated levels of aspartate aminotransferase (n = 18; 19.8%), creatinine (n = 5; 5.5%), and creatine kinase (n = 14; 15.4%) in laboratory tests. Twenty-eight cases (30.8%) suffered non-respiratory injury, including 50% of the critically ill patients and 21.3% of the mild patients. Conclusions Overall, the mortality rate of patients in Jingzhou was lower than that of Wuhan. Importantly, we found liver, kidney, digestive tract, and heart injuries in COVID-19 cases besides respiratory problems. Combining chest computed tomography images with the qPCR analysis of throat swab samples can improve the accuracy of COVID-19 diagnosis. Keywords: COVID-19, Disease characteristics, Mortality, Respiratory failure, Non-respiratory injury Since December 2019, the 2019 coronavirus disease (COVID-19) has expanded to cause a worldwide outbreak that more than 600,000 people infected and tens of thousands died. To date, the clinical characteristics of COVID-19 patients in the non-Wuhan areas of Hubei Province in China have not been described. We retrospectively analyzed the clinical characteristics and treatment progress of 91 patients diagnosed with COVID-19 in Jingzhou Central Hospital. Of the 91 patients diagnosed with COVID-19, 30 cases (33.0%) were severe and two patients (2.2%) died. The severe disease group tended to be older (50.5 vs. 42.0 years; p = 0.049) and have more chronic disease (40% vs. 14.8%; p = 0.009) relative to mild disease group. Only 73.6% of the patients were quantitative polymerase chain reaction (qPCR)-positive on their first tests, while typical chest computed tomography images were obtained for each patient. The most common complaints were cough (n = 75; 82.4%), fever (n = 59; 64.8%), fatigue (n = 35; 38.5%), and diarrhea (n = 14; 15.4%). Non-respiratory injury was identified by elevated levels of aspartate aminotransferase (n = 18; 19.8%), creatinine (n = 5; 5.5%), and creatine kinase (n = 14; 15.4%) in laboratory tests. Twenty-eight cases (30.8%) suffered non-respiratory injury, including 50% of the critically ill patients and 21.3% of the mild patients. Overall, the mortality rate of patients in Jingzhou was lower than that of Wuhan. Importantly, we found liver, kidney, digestive tract, and heart injuries in COVID-19 cases besides respiratory problems. Combining chest computed tomography images with the qPCR analysis of throat swab samples can improve the accuracy of COVID-19 diagnosis. Background Since December 2019, the 2019 coronavirus disease (COVID-19) has expanded to cause a worldwide outbreak that more than 600,000 people infected and tens of thousands died. To date, the clinical characteristics of COVID-19 patients in the non-Wuhan areas of Hubei Province in China have not been described. Methods We retrospectively analyzed the clinical characteristics and treatment progress of 91 patients diagnosed with COVID-19 in Jingzhou Central Hospital. Results Of the 91 patients diagnosed with COVID-19, 30 cases (33.0%) were severe and two patients (2.2%) died. The severe disease group tended to be older (50.5 vs. 42.0 years; p = 0.049) and have more chronic disease (40% vs. 14.8%; p = 0.009) relative to mild disease group. Only 73.6% of the patients were quantitative polymerase chain reaction (qPCR)-positive on their first tests, while typical chest computed tomography images were obtained for each patient. The most common complaints were cough (n = 75; 82.4%), fever (n = 59; 64.8%), fatigue (n = 35; 38.5%), and diarrhea (n = 14; 15.4%). Non-respiratory injury was identified by elevated levels of aspartate aminotransferase (n = 18; 19.8%), creatinine (n = 5; 5.5%), and creatine kinase (n = 14; 15.4%) in laboratory tests. Twenty-eight cases (30.8%) suffered non-respiratory injury, including 50% of the critically ill patients and 21.3% of the mild patients. Conclusions Overall, the mortality rate of patients in Jingzhou was lower than that of Wuhan. Importantly, we found liver, kidney, digestive tract, and heart injuries in COVID-19 cases besides respiratory problems. Combining chest computed tomography images with the qPCR analysis of throat swab samples can improve the accuracy of COVID-19 diagnosis. |
ArticleNumber | 311 |
Audience | Academic |
Author | Xu, Xuan-Xuan Zhao, Xin-Ying Tang, Yuan-Yan Yang, Ai-Ying Yin, Hai-Sen Yu, Bao-Ping Hu, Qin-Ming Xiong, Tao Huang, Zhi-Ping |
Author_xml | – sequence: 1 givenname: Xin-Ying surname: Zhao fullname: Zhao, Xin-Ying – sequence: 2 givenname: Xuan-Xuan surname: Xu fullname: Xu, Xuan-Xuan – sequence: 3 givenname: Hai-Sen surname: Yin fullname: Yin, Hai-Sen – sequence: 4 givenname: Qin-Ming surname: Hu fullname: Hu, Qin-Ming – sequence: 5 givenname: Tao surname: Xiong fullname: Xiong, Tao – sequence: 6 givenname: Yuan-Yan surname: Tang fullname: Tang, Yuan-Yan – sequence: 7 givenname: Ai-Ying surname: Yang fullname: Yang, Ai-Ying – sequence: 8 givenname: Bao-Ping surname: Yu fullname: Yu, Bao-Ping – sequence: 9 givenname: Zhi-Ping surname: Huang fullname: Huang, Zhi-Ping |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32345226$$D View this record in MEDLINE/PubMed |
BookMark | eNqNk9tq3DAQhk1JaQ7tC_SiGHrTQp3qZMvORSEsbbMQSOnxUoyl8a6C19pK8m7zAn3uarNJyIZSii4k5O__5fmZOcz2Bjdglj2n5JjSunobKKtlUxBGClISSor1o-yACkkLxrnYu3fezw5DuCSEypo1T7J9zrgoGasOst-T3g5WQ5_rOXjQEb0N0eqQuy5fQrQ4xJCvbZznjNAm1867AVbWjyE3NiAEzO2QQ57-rfgxziGdPcJGfTa2aPNP3q3soPFNPpnbAU4S6jF6F5aoo11hHuJorp5mjzvoAz672Y-ybx_ef52cFecXH6eT0_NCV5zGopKtANOZRhhapiJQQIW8bA1oQoDRitXUEFKVtQHOsKElRWC8NTXWsu1afpRNt77GwaVaersAf6UcWHV94fxMgU_l96gk1lg1ZSNLJkVNJLQVGGlYyXjTtW2XvN5tvZZju0CjU1Ie-h3T3S-DnauZWylJ61o0Ihm8ujHw7ueIIaqFDRr7HgZ0Y1DpoYoTXoomoS8foJdu9EOKSjFBBGsISewdNYNUgB06l97VG1N1WjHJZSkYSdTxX6i0DC6sTi3W2XS_I3i9I0hMxF9xBmMIavrl8_-zF9932Rf3A7xL7rY7E1BvAZ36JXjslLYx9aTb5Gl7RYnaDILaDoJKg6CuB0Gtk5Q9kN66_0P0BxgvCJo |
CitedBy_id | crossref_primary_10_13105_wjma_v9_i3_220 crossref_primary_10_4236_ijcm_2020_1112060 crossref_primary_10_1016_j_ajem_2020_08_089 crossref_primary_10_1186_s12879_020_05383_y crossref_primary_10_1016_j_dsx_2021_102308 crossref_primary_10_1186_s13054_020_03065_4 crossref_primary_10_1371_journal_pone_0250602 crossref_primary_10_1016_j_clineuro_2020_106183 crossref_primary_10_1186_s12933_020_01159_5 crossref_primary_10_1371_journal_pone_0243191 crossref_primary_10_1016_j_phrs_2020_105107 crossref_primary_10_1002_jmv_26166 crossref_primary_10_1016_j_semnephrol_2020_09_001 crossref_primary_10_1002_jgh3_12456 crossref_primary_10_3390_healthcare9111501 crossref_primary_10_7759_cureus_13894 crossref_primary_10_1097_MD_0000000000034320 crossref_primary_10_2807_1560_7917_ES_2021_26_10_2001134 crossref_primary_10_4103_jgid_jgid_136_20 crossref_primary_10_1016_j_clinre_2020_05_002 crossref_primary_10_3390_diseases8040041 crossref_primary_10_15360_1813_9779_2021_3_65_77 crossref_primary_10_1080_07853890_2020_1790643 crossref_primary_10_1002_rmv_2135 crossref_primary_10_3389_fcvm_2021_757799 crossref_primary_10_1016_j_nmni_2020_100822 crossref_primary_10_1016_j_hest_2023_02_001 crossref_primary_10_1371_journal_pone_0253446 crossref_primary_10_1016_j_clinimag_2020_10_035 crossref_primary_10_3389_fmed_2021_649583 crossref_primary_10_5812_pedinfect_106597 crossref_primary_10_21070_acopen_9_2024_10301 crossref_primary_10_1016_j_mayocp_2020_06_003 crossref_primary_10_1007_s00508_020_01693_y crossref_primary_10_1007_s11239_021_02497_1 crossref_primary_10_1016_j_arcmed_2020_07_005 crossref_primary_10_1080_13813455_2020_1856141 crossref_primary_10_1002_jcla_24959 crossref_primary_10_1016_j_reth_2022_03_006 crossref_primary_10_1016_j_phymed_2022_153930 crossref_primary_10_1007_s10238_021_00715_x crossref_primary_10_3390_tropicalmed8020084 crossref_primary_10_1155_2024_2993144 crossref_primary_10_3390_ijms21186960 crossref_primary_10_1093_tropej_fmab055 crossref_primary_10_21601_ejeph_10955 crossref_primary_10_1002_jmv_26737 crossref_primary_10_1055_s_0040_1719173 crossref_primary_10_52547_iau_32_1_64 crossref_primary_10_1016_j_nefroe_2022_11_005 crossref_primary_10_4103_jfmpc_jfmpc_1754_21 crossref_primary_10_1371_journal_pone_0249481 crossref_primary_10_31083_j_ceog_2020_05_2223 crossref_primary_10_3389_fmed_2021_588013 crossref_primary_10_1093_nutrit_nuaa126 crossref_primary_10_1136_bmjebm_2020_111536 crossref_primary_10_1002_ehf2_13061 crossref_primary_10_1136_bmjopen_2020_044640 crossref_primary_10_36290_vnl_2021_118 crossref_primary_10_18678_dtfd_776953 crossref_primary_10_1016_j_cca_2020_07_018 crossref_primary_10_1186_s40560_020_00508_6 crossref_primary_10_3389_fmed_2020_00458 crossref_primary_10_1016_j_biochi_2022_01_015 crossref_primary_10_1186_s12879_021_05915_0 crossref_primary_10_1021_acschemneuro_1c00353 crossref_primary_10_1097_MPA_0000000000001824 crossref_primary_10_1155_2022_5978314 crossref_primary_10_1038_s41598_021_82492_x crossref_primary_10_1016_j_nefro_2021_09_002 crossref_primary_10_1016_j_bja_2020_06_044 crossref_primary_10_1002_edm2_338 crossref_primary_10_1007_s00405_021_06900_8 crossref_primary_10_1007_s00535_021_01778_z crossref_primary_10_1177_0300060520972658 crossref_primary_10_3389_fphar_2020_570721 crossref_primary_10_1016_j_bspc_2022_104197 crossref_primary_10_1590_1980_57642021dn15_010001 crossref_primary_10_1007_s10072_020_04801_y crossref_primary_10_1016_j_ajem_2020_10_022 crossref_primary_10_2147_SCCAA_S333800 crossref_primary_10_1111_ans_16260 crossref_primary_10_2174_0118749445311125240521103318 crossref_primary_10_1186_s44158_022_00046_7 crossref_primary_10_1002_jmv_26081 crossref_primary_10_1038_s41598_020_77698_4 crossref_primary_10_1016_j_dsx_2021_02_012 crossref_primary_10_1080_17474124_2020_1794812 crossref_primary_10_1136_bmjopen_2020_044661 crossref_primary_10_2147_CIA_S268607 crossref_primary_10_1136_bmjopen_2020_047016 crossref_primary_10_1155_2021_6650469 crossref_primary_10_1016_j_bspc_2022_104241 crossref_primary_10_1093_ofid_ofad105 crossref_primary_10_3390_life11111127 crossref_primary_10_7717_peerj_10771 crossref_primary_10_1097_MD_0000000000026283 crossref_primary_10_1007_s00467_020_04617_0 crossref_primary_10_37349_ei_2024_00126 crossref_primary_10_1002_clc_23465 crossref_primary_10_1136_gutjnl_2020_322072 crossref_primary_10_1080_10826076_2023_2168691 crossref_primary_10_2217_fmb_2022_0041 crossref_primary_10_1016_j_jstrokecerebrovasdis_2021_105805 crossref_primary_10_21876_rcshci_v10i2_985 crossref_primary_10_3389_fphar_2021_607408 crossref_primary_10_1007_s40119_020_00189_0 crossref_primary_10_1513_AnnalsATS_202006_600FR crossref_primary_10_34883_PI_2020_23_5_001 crossref_primary_10_1159_000512211 crossref_primary_10_1038_s41598_021_89419_6 crossref_primary_10_1136_bmjopen_2020_042090 crossref_primary_10_1186_s43066_022_00171_6 crossref_primary_10_1007_s11154_021_09630_8 crossref_primary_10_30699_jambs_29_136_302 crossref_primary_10_1016_j_rmed_2021_106668 crossref_primary_10_1007_s10620_021_07158_0 crossref_primary_10_1111_jocs_14808 crossref_primary_10_1002_hbe2_237 crossref_primary_10_1016_j_reth_2021_05_007 crossref_primary_10_1177_2040622321998860 crossref_primary_10_1002_iid3_471 crossref_primary_10_1155_2021_8863053 crossref_primary_10_17116_jnevro202112112113 crossref_primary_10_7759_cureus_13317 crossref_primary_10_1136_bmjgast_2020_000571 crossref_primary_10_22416_1382_4376_2020_30_6_51_56 crossref_primary_10_1093_ckj_sfaa160 crossref_primary_10_1016_j_chest_2020_10_054 crossref_primary_10_1016_j_phrs_2020_105250 crossref_primary_10_3748_wjg_v28_i46_6599 crossref_primary_10_1017_S0950268821000224 crossref_primary_10_1155_2021_6662476 crossref_primary_10_1093_cid_ciab493 crossref_primary_10_1111_jan_14558 crossref_primary_10_4103_TPSY_TPSY_6_22 crossref_primary_10_1016_j_cmi_2020_12_018 crossref_primary_10_5114_amsad_2022_115008 crossref_primary_10_1097_CRD_0000000000000422 crossref_primary_10_5662_wjm_v12_i5_365 crossref_primary_10_3390_ijerph17249360 crossref_primary_10_3390_jcm9123932 |
Cites_doi | 10.1017/ice.2015.348 10.1101/2020.01.22.914952 10.1038/nature02145 10.1002/path.1570 10.1084/jem.20050828 10.1001/jama.2020.1623 10.1056/NEJMoa2001017 10.1378/chest.129.6.1441 10.1080/22221751.2020.1719902 10.1016/S0140-6736(20)30211-7 10.1002/ddr.21656 10.1001/jama.2020.1585 10.1101/2020.01.31.929042 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2020 BioMed Central Ltd. 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2020 |
Copyright_xml | – notice: COPYRIGHT 2020 BioMed Central Ltd. – notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2020 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QL 7T2 7U9 7X7 7XB 88E 8C1 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BENPR C1K CCPQU COVID DWQXO FYUFA GHDGH H94 K9. M0S M1P M7N PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12879-020-05010-w |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Health and Safety Science Abstracts (Full archive) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Public Health Database (ProQuest) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College Coronavirus Research Database ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest One Sustainability Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection AIDS and Cancer Research Abstracts Health & Safety Science Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1471-2334 |
EndPage | 8 |
ExternalDocumentID | oai_doaj_org_article_7e8e695975274807ab6ad7d25239fbbf PMC7188494 A627375420 32345226 10_1186_s12879_020_05010_w |
Genre | Journal Article |
GeographicLocations | China United States--US Hubei China |
GeographicLocations_xml | – name: China – name: Hubei China – name: United States--US |
GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8C1 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR IOV ISR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB -A0 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF NPM PMFND 7QL 7T2 7U9 7XB 8FK AZQEC C1K COVID DWQXO H94 K9. M7N PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c631t-67b4adfd94d15323e4a6e35bdac00a216281d00658da32e9151ea23bd8e87bfb3 |
IEDL.DBID | M48 |
ISSN | 1471-2334 |
IngestDate | Wed Aug 27 01:08:32 EDT 2025 Thu Aug 21 18:28:17 EDT 2025 Fri Jul 11 10:15:40 EDT 2025 Fri Jul 25 23:34:28 EDT 2025 Tue Jun 17 21:35:07 EDT 2025 Tue Jun 10 20:33:17 EDT 2025 Fri Jun 27 04:23:29 EDT 2025 Fri Jun 27 04:05:30 EDT 2025 Thu Jan 02 22:59:26 EST 2025 Thu Apr 24 23:04:03 EDT 2025 Tue Jul 01 01:57:42 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | COVID-19 Non-respiratory injury Respiratory failure Disease characteristics Mortality |
Language | English |
License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c631t-67b4adfd94d15323e4a6e35bdac00a216281d00658da32e9151ea23bd8e87bfb3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12879-020-05010-w |
PMID | 32345226 |
PQID | 2404290096 |
PQPubID | 42582 |
PageCount | 8 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_7e8e695975274807ab6ad7d25239fbbf pubmedcentral_primary_oai_pubmedcentral_nih_gov_7188494 proquest_miscellaneous_2396303549 proquest_journals_2404290096 gale_infotracmisc_A627375420 gale_infotracacademiconefile_A627375420 gale_incontextgauss_ISR_A627375420 gale_incontextgauss_IOV_A627375420 pubmed_primary_32345226 crossref_citationtrail_10_1186_s12879_020_05010_w crossref_primary_10_1186_s12879_020_05010_w |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-04-29 |
PublicationDateYYYYMMDD | 2020-04-29 |
PublicationDate_xml | – month: 04 year: 2020 text: 2020-04-29 day: 29 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC infectious diseases |
PublicationTitleAlternate | BMC Infect Dis |
PublicationYear | 2020 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | JF Chan (5010_CR10) 2020; 9 5010_CR13 J Gu (5010_CR1) 2005; 202 5010_CR12 N Chen (5010_CR4) 2020; 395 5010_CR3 W Li (5010_CR11) 2003; 426 N Zhu (5010_CR14) 2020; 382 RC Chen (5010_CR15) 2006; 129 5010_CR9 5010_CR7 5010_CR5 ADT Force (5010_CR6) 2012; 307 TW Auyeung (5010_CR16) 2005; 51 I Hamming (5010_CR8) 2004; 203 K Bedell (5010_CR2) 2016; 37 |
References_xml | – volume: 307 start-page: 2526 issue: 23 year: 2012 ident: 5010_CR6 publication-title: Jama – ident: 5010_CR13 – volume: 37 start-page: 598 issue: 5 year: 2016 ident: 5010_CR2 publication-title: Infect Control Hosp Epidemiol doi: 10.1017/ice.2015.348 – ident: 5010_CR9 doi: 10.1101/2020.01.22.914952 – volume: 426 start-page: 450 issue: 6965 year: 2003 ident: 5010_CR11 publication-title: Nature doi: 10.1038/nature02145 – volume: 203 start-page: 631 issue: 2 year: 2004 ident: 5010_CR8 publication-title: J Pathol doi: 10.1002/path.1570 – volume: 202 start-page: 415 issue: 3 year: 2005 ident: 5010_CR1 publication-title: J Exp Med doi: 10.1084/jem.20050828 – ident: 5010_CR3 doi: 10.1001/jama.2020.1623 – volume: 382 start-page: 727 issue: 8 year: 2020 ident: 5010_CR14 publication-title: N Engl J Med doi: 10.1056/NEJMoa2001017 – volume: 129 start-page: 1441 issue: 6 year: 2006 ident: 5010_CR15 publication-title: Chest doi: 10.1378/chest.129.6.1441 – volume: 9 start-page: 221 issue: 1 year: 2020 ident: 5010_CR10 publication-title: Emerg Microbes Infect doi: 10.1080/22221751.2020.1719902 – volume: 395 start-page: 507 issue: 10223 year: 2020 ident: 5010_CR4 publication-title: Lancet doi: 10.1016/S0140-6736(20)30211-7 – ident: 5010_CR12 doi: 10.1002/ddr.21656 – volume: 51 start-page: 98 issue: 2 year: 2005 ident: 5010_CR16 publication-title: J Inf Secur – ident: 5010_CR5 doi: 10.1001/jama.2020.1585 – ident: 5010_CR7 doi: 10.1101/2020.01.31.929042 |
SSID | ssj0017829 |
Score | 2.6078532 |
Snippet | Since December 2019, the 2019 coronavirus disease (COVID-19) has expanded to cause a worldwide outbreak that more than 600,000 people infected and tens of... Background Since December 2019, the 2019 coronavirus disease (COVID-19) has expanded to cause a worldwide outbreak that more than 600,000 people infected and... Abstract Background Since December 2019, the 2019 coronavirus disease (COVID-19) has expanded to cause a worldwide outbreak that more than 600,000 people... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 311 |
SubjectTerms | Adult Aspartate Aspartate aminotransferase Betacoronavirus Care and treatment Chest China - epidemiology Chronic diseases Chronic illnesses Computed tomography Coronaviridae Coronavirus infections Coronavirus Infections - complications Coronavirus Infections - diagnostic imaging Coronavirus Infections - epidemiology Coronavirus Infections - therapy Coronaviruses Cough Cough - etiology COVID-19 Creatine Creatine kinase Creatinine Diagnostic imaging Diarrhea Diarrhea - etiology Disease characteristics Disease Outbreaks Fatalities Fatigue - etiology Female Fever Fever - etiology Gastrointestinal tract Health aspects Humans Infectious diseases Injuries Kidneys Kinases Laboratory tests Male Medical imaging Middle Aged Mortality Non-respiratory injury Pandemics Patients Pneumonia, Viral - complications Pneumonia, Viral - diagnostic imaging Pneumonia, Viral - epidemiology Pneumonia, Viral - therapy Polymerase chain reaction Respiratory failure Respiratory function Retrospective Studies SARS-CoV-2 Tomography, X-Ray Computed Viral diseases |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA9yD-KL-O3qKVEEH7Rcm68mvp3isQqnop7eW0ia1Fs4Wtluvf_Av9tJmi4bRH3xbWkm0J2ZzPymSX6D0BNwGi4NbQvmDSmYI7KwlMnCCCg3JOdOVeHu8PE7sTxhb0_56U6rr3AmbKIHnhR3UHvphQLYy6F-kmVtrDCudgQKKNVa24boCzlvLqbS_gHkPTVfkZHiYIAoXKsilEolD9u_F1kaimz9v8fknaSUH5jcyUBH19DVBB3x4fTK19El391Al4_T5vhN9DNxfJ7jJmdhxn2LE3_qgMOHVwz5WOEmkBeYH6v1OOC0T4NXHTa467vi63hm4DdAyjB7OVq_wh_i54fGP8ex6_YLEF37zbqfb2viyFV7C50cvf78almkNgtFI2i1KURtmXGtU8xB-CPUMyM85daZpiwNqQQBTBuhijOUeAUYAexKrZNe1ra19DbagxfzdxG2vCHWeasoIDNKaisk945VBlCYd1IuUDVrXTeJgzy0wjjXsRaRQk-W0mApHS2lLxbo2XbO94mB46_SL4Mxt5KBPTs-AJ_Syaf0v3xqgR4HV9CBH6MLB3C-mXEY9Jv3X_ShALwXugaXfxL69DETepqE2h7-aGPSpQdQV-DdyiT3M0lY5U0-PLulTlFm0IDGAE6EKnSBHm2Hw8xwcq7z_QgyFEJsSTlTC3Rn8uKtcsDYgVAfZteZf2fay0e61VnkIAdII5li9_6Huu-jKyQuTVYQtY_2NuvRPwCot7EP46r-BT4cTu4 priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgLKu-lBRmExAGiJrbj2FxQQVQLUgEBhb1Zduy0K1VJ2WzoP-B3M-P1Lo0QvUXxWEo845lv_PiGkGdgNKWyvMlEsCwTnqnMcaEyKyHdUGXpdYF3hw8_yumR-DArZ2nBrU_HKtc-MTpq39W4Rr4HkQdcJyLu12c_M6wahburqYTGVXINqcvQqqvZJuEqIPrp9UUZJfd68MWVzjBhykvcBD4fBaPI2f-vZ74QmsbHJi_EoYNtcjMBSLq_0vgtciW0t8n1w7RFfof8Tkyfp7QeczHTrqGJRbWnuPxKISprWiOFgf01Xww9Tbs1dN5SS9uuzX4MJxaeAVhi7-ngwpx-josQdXhJY-3tVyC6CMtFt76zSSNj7V1ydPDu29tplootZLXkxTKTlRPWN14LD06Q8SCsDLx03tZ5blkhGSDbCFi85SxoQAqgXe68CqpyjeP3yBZ8WHhAqCtr5nxwmgM-46xyUpXBi8ICFgteqQkp1qNu6sREjgUxTk3MSJQ0K00Z0JSJmjLnE_Ji0-dsxcNxqfQbVOZGEjm044tucWzSlDRVUEGC0VQlZOYqr6yT1leeQWquG-eaCXmKpmCQJaPFYzjHduh78_7Td7MvAfVh7eD8f0Jfv4yEniehpoMfrW26-gDDhexbI8ndkSTM9XrcvDZLk3xNb_7OjAl5smnGnnh-rg3dADIcHG3OS6En5P7KijeDA8pGWn3oXY3sezR645Z2fhKZyAHYKKHFw8s_a4fcYHHSiYzpXbK1XAzhEUC5pXsc5-sfvttGeg priority: 102 providerName: ProQuest |
Title | Clinical characteristics of patients with 2019 coronavirus disease in a non-Wuhan area of Hubei Province, China: a retrospective study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/32345226 https://www.proquest.com/docview/2404290096 https://www.proquest.com/docview/2396303549 https://pubmed.ncbi.nlm.nih.gov/PMC7188494 https://doaj.org/article/7e8e695975274807ab6ad7d25239fbbf |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bb9MwFLZ2kRAviDuFURmExAMEkthxbCSE1mnTQOqYCoVqL5YdO1ulKoGkYfAH-N0cu0lZxOCJl6iqj6X2XHy-Y8ffQegJOE3CFckDalUcUBPzQBPKA8Wg3OBJYkTk7g6Pj9jhlL6bJbMN1LU7ahVYX1rauX5S02rx4vvXH28g4F_7gOfsZQ1rbCoCVwiFiTvcPd9E25CZUtfRYEx_nypANhTdxZlL5_WSk-fw_3OlvpCq-q9RXshLB9fRtRZQ4t2VB9xAG7a4ia6M2yPzW-hny_y5wFmfmxmXOW5ZVWvstmMxZGmBM0dpoL7Nq6bG7ekNnhdY4aIsgs_NmYLPADTd7MNG2zk-9psSmX2OfS_uVyBa2WVVdnc4sWewvY2mB_sf9w6DtvlCkDESLQOWaqpMbgQ1sCjGxFLFLEm0UVkYqjhiMSBdD2CMIrEVgBzA2kQbbnmqc03uoC34YfYewjrJYm2sFgTwGolTzXhiDY0UYDNrOB-gqNO6zFpmctcgYyF9hcKZXFlKgqWkt5Q8H6Bn6zlfVrwc_5QeOWOuJR2ntv-irE5lG6IytdwyAQVWApU6D1OlmTKpiaFUF7nW-QA9dq4gHWtG4V7LOVVNXcu37z_JXQYo0PUSDv8m9GHSE3raCuUl_NFMtVchQF2OjasnudOThNjP-sOdW8oudCRgNAAZrjYdoEfrYTfTvU9X2LIBGQILb0gSKgbo7sqL18oBYzuafZid9vy7p73-SDE_88zkAHQ4FfT-_1D3A3Q19qFJg1jsoK1l1diHAACXeog201kKT74XDdH2aP_oeDL0mylDH-_wnIxOfgE0t1w0 |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGkIAXxDeFAQaBeIBoje0kNhJCYzC17APENtibsWNnqzQlo2mp-Af4c_gbuXOTsgixt71V8blKfOf7sO9-R8hTEJpEGl5EwhsWCcdkZLmQkUkh3JBJ4lSMtcPbO-lgX3w4SA6WyO-2FgbTKludGBS1q3I8I18FywOqEz3uNyffI-wahberbQuNuVhs-p8zCNnq18N3wN9njG2831sfRE1XgShPeTyJ0swK4wqnhIPdzrgXJvU8sc7k_b5hccrAhQuW2RnOvAKTCJ_BrZNeZrawHP73ArkoOGxNrExfX6SUxGBtVVuYI9PVGnR_piIM0PoJXjrPOsYv9Aj41xKcMoXdNM1Tdm_jGrnaOKx0bS5h18mSL2-QS9vNlfxN8qtBFj2meRf7mVYFbVBba4rHvRS8AEVzhEwwP0bjaU2b2yE6KqmhZVVGX6dHBn6DI4uzB1PrR_RTOPTI_Usaen2_AtKxn4yrtkaUBoTcW2T_XNhwmyzDi_m7hNokZ9Z5qzj4g5xlNpWJdyI24Pt5J2WPxO2q67xBPscGHMc6REAy1XNOaeCUDpzSsx55sZhzMsf9OJP6LTJzQYmY3eFBNT7UjQrQmZc-VRDAJSzDQn5jU-MyxxLGVWFt0SNPUBQ0onKUmPZzaKZ1rYcfv-i1FLxM7FXc_x_R7ucO0fOGqKjgQ3PTlFrAciHaV4dypUMJuiXvDrdiqRvdVuu_O7FHHi-GcSbm65W-mgINB8Xe54lQPXJnLsWLxQFmI4w_zM468t1Zve5IOToKyOfgSEmhxL2zX-sRuTzY297SW8OdzfvkCgsbUERMrZDlyXjqH4AbObEPw96l5Nt5K4s_LWmDcw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+characteristics+of+patients+with+2019+coronavirus+disease+in+a+non-Wuhan+area+of+Hubei+Province%2C+China%3A+a+retrospective+study&rft.jtitle=BMC+infectious+diseases&rft.au=Xin-Ying+Zhao&rft.au=Xuan-Xuan+Xu&rft.au=Hai-Sen+Yin&rft.au=Qin-Ming+Hu&rft.date=2020-04-29&rft.pub=BMC&rft.eissn=1471-2334&rft.volume=20&rft.issue=1&rft.spage=1&rft.epage=8&rft_id=info:doi/10.1186%2Fs12879-020-05010-w&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_7e8e695975274807ab6ad7d25239fbbf |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2334&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2334&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2334&client=summon |